Lexaria Bioscience (QX) Stock Price - LXRP

0.50
0.0025 (0.50%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexaria Bioscience Corporation (QX) LXRP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0025 0.5% 0.50 0.4861 0.52 0.496 0.4975 16:30:28
Bid Price Ask Price Spread Spread % News
0.493 0.50 0.007 1.4% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
40 43,290 $ 0.502381 $ 21,748 99,607 0.3037 - 1.57
Last Trade Time Type Quantity Stock Price Currency
15:53:18 500 $ 0.50 USD

Lexaria Bioscience (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 40.36M 80.72M $ -6.60M - - 62.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
210.00 $ - 0.00% - -

more financials information »

Lexaria Bioscience (QX) News

Loading Messages....

Latest LXRP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.460.520.4450.48890451,9080.048.7%
1 Month0.5140.560.430.49605857,443-0.014-2.72%
3 Months0.47260.570.30370.4269482102,0120.02745.8%
6 Months0.860.940.30370.520062197,922-0.36-41.86%
1 Year1.401.570.30370.785707497,814-0.90-64.29%
3 Years0.5552.540.271.22188,097-0.055-9.91%
5 Years0.09012.540.0760.9039154170,4460.4099454.94%

Lexaria Bioscience (QX) Description

Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October. 2016. Lexaria's technology provides increases of up to 1Ox in intestinal absorption rates; more rapid delivery to the bloodstream with effects often with in 15-20 minutes; and important taste-masking benefits for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.